J Mattern
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 18
- Angiogenesis and VEGF in Cancer 11
- Glutathione Transferases and Polymorphisms 10
- Oncology 59
- Drug Transport and Resistance Mechanisms 26
- Co-authors
- M Volm (106 shared papers)Reet Koomägi (28 shared papers)Thomas Efferth (19 shared papers)Ingrid Herr (11 shared papers)G. Stammler (11 shared papers)K. Wayss (35 shared papers)Dirk Moritz (1 shared paper)M. Kaufmann (11 shared papers)
In The Last Decade
J Mattern
134 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 109
- Oncology 1.4k
- Cancer Research 653
- Genetics 256
- Molecular Biology 1.6k
- Radiology, Nuclear Medicine and Imaging 416
Countries citing papers authored by J Mattern
This map shows the geographic impact of J Mattern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mattern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mattern more than expected).
Fields of papers citing papers by J Mattern
This network shows the impact of papers produced by J Mattern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mattern. The network helps show where J Mattern may publish in the future.
Co-authors
The 25 scholars most cited alongside J Mattern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 350 | |
| 2 | 1999 | 323 | |
| 3 | 1996 | 279 | |
| 4 | 2008 | 200 | |
| 5 | 1994 | 176 | |
| 6 | 1989 | 116 | |
| 7 | 2013 | 105 | |
| 8 | 1997 | 88 | |
| 9 | 1993 | 84 | |
| 10 | 1997 | 69 | |
| 11 | 1995 | 67 | |
| 12 | 1991 | 66 | |
| 13 | Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. | 2000 | 63 |
| 14 | 2002 | 56 | |
| 15 | Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. | 1997 | 48 |
| 16 | 2016 | 42 | |
| 17 | Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. | 1997 | 42 |
| 18 | 2005 | 41 | |
| 19 | PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. | 1999 | 41 |
| 20 | Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. | 1999 | 39 |
About J Mattern
J Mattern is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 140 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Drug Transport and Resistance Mechanisms (26 papers), Cancer therapeutics and mechanisms (18 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Angiogenesis and VEGF in Cancer (11 papers), Cancer Research and Treatments (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Glutathione Transferases and Polymorphisms (10 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (653 citations), Genetics (256 citations), Molecular Biology (1.6k citations) and Radiology, Nuclear Medicine and Imaging (416 citations). J Mattern has collaborated with scholars based in Germany, Hungary and Estonia. Frequent co-authors include M Volm, Reet Koomägi, Thomas Efferth, Ingrid Herr, G. Stammler, K. Wayss, Dirk Moritz, M. Kaufmann, Bernd Groner and Winfried S. Wels. Their work appears in journals such as International Journal of Oncology, British Journal of Cancer, Lung Cancer, Oncology Reports and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.